Ravi Salgia to Central Nervous System Neoplasms
This is a "connection" page, showing publications Ravi Salgia has written about Central Nervous System Neoplasms.
Connection Strength
0.597
-
The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer. Future Oncol. 2018 Aug; 14(19):1897-1908.
Score: 0.597
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.